"Our last two years have been the biggest commitment of capital in our history," said Larry Webster, CEO of Upstate Niagara Cooperative, which is supplying the milk to both Alpina Foods' and M眉ller Quaker Dairy's yogurt plants.
Webster won't say exactly how much capital he's talking about, but the investment includes buying a yogurt plant in the northern part of New York state and expanding its western New York plants. Upstate is also an owner of O-At-Ka Milk Products Cooperative, which has expanded its Batavia, N.Y., plant, too.
Hot Cheap Stocks To Buy For 2016: Choice Hotels International Inc. (CHH)
Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor worldwide. It franchises lodging properties under its proprietary brand names, including Comfort Inn, Comfort Suites, Quality, Clarion, Sleep Inn, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Extended Stay Hotel, Cambria Suites, and Ascend Collection brands. As of March 31, 2011, it operated 6,128 open hotels comprising 492,733 rooms, as well as 606 hotels consisting of 49,908 rooms under construction, awaiting conversion, or approved for development in 49 states, and the District of Columbia in the United States; and approximately 40 countries and other territories. The company was founded in 1981 and is based in Silver Spring, Maryland.
Advisors' Opinion:- [By John Udovich]
Small cap hotel stock La Quinta Holdings Inc (NYSE: LQ) just had its IPO to raise a lower than expected $650 million after being priced below its expected range, meaning its worth taking a closer look at the stock which�is focused on the�mid-priced hotel market along with the performance of potential benchmarks like hotel stocks Marriott International Inc (NASDAQ: MAR), Choice Hotels International Inc (NYSE: CHH) and Wyndham Worldwide Corporation (NYSE: WYN).
Top 10 Trucking Companies To Own For 2015: Pozen Inc.(POZN)
POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and other pain-related conditions in the United States. Its products include Treximet for acute treatment of migraine attacks with or without aura in adults; and VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing non-steroidal anti-inflammatory drugs (NSAID)-associated gastric ulcers. The company also develops PA32540, a product candidate, which is under 2 pivotal Phase 3 trials for the secondary prevention of cardiovascular disease in patients at risk for gastric ulcers. It has collaborations with GlaxoSmithKline for the development and commercialization of proprietary combinations of a triptan and a long-acting NSAID; and with AstraZeneca AB for the development and commercialization of proprietary fixed dose combi nations of the proton pump inhibitor esomeprazole magnesium with the NSAID naproxen. The company was founded in 1996 and is headquartered in Chapel Hill, North Carolina.
Advisors' Opinion:- [By Monica Gerson]
POZEN (NASDAQ: POZN) shares fell 18.96% to $7.82 in the pre-market trading. POZEN's trailing-twelve-month ROE is -25.44%.
The Walt Disney Company (NYSE: DIS) dipped 1.63% to $74.99 in the pre-market session. Disney's trailing-twelve-month profit margin is 13.62%.
Top 10 Trucking Companies To Own For 2015: Astrotech Corporation(ASTC)
Astrotech Corporation operates as a commercial aerospace company in the United States. The company provides spacecraft payload processing and related services; designs and manufactures space hardware; and commercializes space technologies for use on the earth. It also offers satellite launch processing support to government and commercial customers for their communication, earth observation, and deep space satellites. The company?s processing activities consist of satellite ground transportation; pre-launch hardware integration and testing; satellite encapsulation, fueling, launch pad delivery; and communication linked launch control, as well as engineering services. In addition, it develops Miniature Chemical Detector, a chemical analyzer for use on international space station, as well as detects residues and vapors from a range of chemicals, including explosives, chemical warfare agents, toxic chemicals, and volatile organic compounds. The company serves the United Stat es Government and commercial satellite and spacecraft customers. Astrotech Corporation was founded in 1984 is headquartered in Austin, Texas.
Advisors' Opinion:- [By Peter Graham]
The Q3 2014 earnings report for small cap space stock Orbital Sciences Corp (NYSE: ORB), a potential peer of Alliant Techsystems Inc (NYSE: ATK) who ORB is actually merging with plus Astrotech Corp (NASDAQ: ASTC) which actually just completed the sale of�part of its�space business to subsidiary of Lockheed Martin Corporation (NYSE: LMT) and Toronto listed Macdonald Dettwiler & Associates Ltd (TSE: MDA), is scheduled for before the market opens on Thursday (October 16th). Aside from the Orbital Sciences Corp earnings report, it should be said that Alliant Techsystems Inc will report earnings before the market opens on October 30th; Astrotech Corp reported Q4 2014 earnings on September 29th (they completed the sale of Astrotech Space Operations in August); and Macdonald Dettwiler & Associates Ltd will report earnings on October 29th after the market closes.��
- [By Quick Pen]
American aerospace and defense giant Lockheed Martin (LMT) recently announced its plans of acquiring the satellite wing of Astrotech Corp. (ASTC), Astrotech Space Operations. Lockheed expects to close the deal by the third quarter of the current year. After the deal closes, Astrotech Space Operations would become the wholly owned subsidiary of Lockheed Martin and would operate under the company�� Space Systems business segment.
- [By Roberto Pedone]
Astrotech (ASTC) operates as a commercial aerospace company in the U.S. This stock closed up 7.2% to $3.26 a share in Thursday's trading session.
Thursday's Range: $3.02-$3.31
52-Week Range: $0.61-$4.05
Thursday's Volume: 295,000
Three-Month Average Volume: 570,805From a technical perspective, ASTC spiked sharply higher here right above some near-term support at $2.96 with lighter-than-average volume. This stock has been uptrending strong for the last four months, with shares moving higher from its low of 63 cents per share to its recent high of $4.05. During that uptrend, shares of ASTC have been making mostly higher lows and higher highs, which is bullish technical price action. This spike on Thursday is now starting to push shares of ASTC within range of triggering a major breakout trade. That trade will hit if ASTC manages to take out some near-term overhead resistance levels at $3.50 to $3.75 and then once it takes out its 52-week high at $4.05 with high volume.
Traders should now look for long-biased trades in ASTC as long as it's trending above its 50-day at $2.66 or above more near-term support at $2.62 and then once it sustain a move or close above those breakout levels with volume that hits near or above 570,805 shares. If that breakout hits soon, then ASTC will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets of that breakout are $5 to $5.50.
Top 10 Trucking Companies To Own For 2015: CCR SA (CCRO3)
CCR SA is a Brazil-based holding company primarily engaged in the operation of highways. The Company's businesses are divided into five main operating segments: Highway which includes concessions such as AutoBAn, ViaOeste, NovaDutra, RodoNorte, SPVias, Ponte, ViaLagos, RodoAnel Oeste, Transolimpica and Renovias; Subway which includes ViaQuatro, Sea Transportation which includes Barcas concession; Airport Concessions which include Quiport, Aeris and CAP, and all companies related to these concessions; and Services/Holdings which is related to sub-holdings CPC and CCR Espana, among others. It is involved in the collection of toll fees on highways and is responsible for repairing, conserving, maintaining and operating of these highways. It is responsible for national highways network in Brazilian states of Sao Paulo, Rio de Janeiro and Parana. Additionally, it is active in automotive inspection services, automatic toll payment and automatic vehicle identification systems operation. Advisors' Opinion:- [By Ney Hayashi]
Toll-road operator CCR SA (CCRO3) added 3.1 percent to 16.75 reais, snapping a five-day rout that drove shares 11 percent lower. Competitor EcoRodovias Infraestrutura e Logistica SA gained 1.7 percent to 14.75 reais today.
Top 10 Trucking Companies To Own For 2015: Roche Holding AG (RHHBY)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company�� products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company�� Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division�� research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty NMEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.
In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer�� disease and schizophrenia.
Pharmaceuticals
Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche�� Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.
Diagnostics
Roche�� Diagnostics Division is a supplier of in vitro diagnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche�� Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.
Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors��offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antibody assay for the diagnosis of Graves��disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care�� products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche�� ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science�� business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.
Advisors' Opinion:- [By Bryan Murphy]
When most investors think of cancer stocks, names like Amgen, Inc. (NASDAQ:AMGN) or Roche Holding Ltd. (OTCMKTS:RHHBY) come to mind. And to be fair, they're both top-of-mind names for good reasons. Five of the world's top-ten selling cancer drugs are from Roche Holding, and Amgen is the world's biggest biotech company; it just spent $10 billion on the acquisition of an entire company almost to add just one cancer therapy to its library. Thing is, while Roche Holding Ltd. and Amgen, Inc. make top-notch drugs to treat cancer once acquired, neither actually does anything to prevent the development of cancer through metastasization. Indeed, the prevention of the spread of cancer isn't on the biopharma industry's radar at all, save one company - a little outfit called MetaStat Inc. (OTCBB:MTST).
- [By Alex Planes]
Genentech would eventually develop a number of important new medical products, beginning with synthetic insulin, its very first FDA-approved product in 1982, and the first genetically engineered human theraputic. Genentech's success eventually led to one of the largest acquisitions in health-care history, as Roche (NASDAQOTH: RHHBY ) took full control of Genentech for roughly $47 billion in 2009 after holding majority ownership since 1990.
- [By James E. Brumley]
I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that's played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it's earning the right to be compared to the likes of bigger brothers in the cancer-treatment space... names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).
- [By Dan Carroll and Max Macaluso, Ph.D.]
Glaxo's staring down some tough competition. Roche (NASDAQOTH: RHHBY ) and Bristol-Myers Squibb (NYSE: BMY ) each made hundreds of millions of dollars in sales last year after both had drugs approved for melanoma in 2011. Can Glaxo rise up to carve out a lucrative niche in this space? In the following video, Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what's in store for this company's melanoma drugs.
Top 10 Trucking Companies To Own For 2015: Caplease Funding Inc (LSE)
CapLease, Inc. operates as a real estate investment trust (REIT), focused on financing and investing in commercial real estate that is net leased primarily to single tenants with investment grade or near investment grade credit ratings. It provides private and corporate owners of net lease real estate with equity, debt, and mezzanine financing options. The company is organized to qualify as a REIT for federal income tax purposes and accordingly it distributes at least 90% of its taxable income to its stockholders. Capital Lease is based in New York City.
Advisors' Opinion:- [By Nandini Sukumar]
London Stock Exchange Group Plc (LSE) hired Brian Schwieger from Bank of America Corp.�� Merrill Lynch unit, three people with knowledge of the plans said.
Top 10 Trucking Companies To Own For 2015: Western Digital Corp (WDC)
Western Digital Corporation (WD) is a provider of solutions for the collection, storage, management, protection and use of digital content, including audio and video. Its principal products are hard drives, which are devices that use one or more rotating magnetic disks (magnetic media) to store and allow access to data. Its hard drives are used in desktop and notebook computers, corporate and cloud computing data centers, home entertainment equipment and stand-alone consumer storage devices. In addition to hard drives, its other products include solid-state drives and home entertainment and networking products. The Company operates as the parent company of its hard drive business, Western Digital Technologies, Inc. Effective March 8, 2012, the Company acquired Viviti Technologies Ltd. In May 2012, the Company completed the divestiture of certain 3.5-inch hard drive assets to Toshiba Corporation. As part of its deal with Toshiba, WD also completed its purchase of Toshiba Storage Device (Thailand) Company Limited (TSDT), which manufactured hard drives.
The Company offers a line of storage devices. Its hard drives include 3.5-inch and 2.5-inch form factors, capacities ranging from 80 gigabytes to three terabytes, nominal rotation speeds up to 10,000 revolutions per minute, and interfaces, such as Serial Advanced Technology Attachment (SATA) and Serial Attached SCSI (Small Computer System Interface) (SAS). In addition, the Company offers a family of hard drives specifically designed to consume less power than standard drives, utilizing its WD GreenPower Technology. Its solid-state drives include 2.5-inch and Compact Flash form factors, capacities ranging from 1 gigabyte to 256 gigabytes, and interfaces, such as SATA and PATA.
Client Compute Storage Products
Client compute consists of hard drives and solid-state drives for desktop and mobile personal computers (PC��). During the fiscal year ended July 1, 2011 (fiscal 2011), it shipped 151 million hard drive clie! nt compute unit. Its client compute storage products include WD Caviar, WD Scorpio and WD Silicon Edge. WD Caviar family of hard drives is designed for use in desktop PCs. WD Scorpio family of hard drives is designed for use in mobile PCs. WD Silicon Edge family of solid-state drives is designed for both read-intensive client/consumer applications and write-intensive original equipment manufacturer (OEM) applications.
Client Non-Compute Storage Products
Client non-compute consists of branded products and consumer electronics products. Its hard drive client non-compute unit shipments were 46 million, during fiscal 2011.
Branded Products
Branded products consists of hard drives embedded into WD-branded external storage appliances with capacities ranging from 250 gigabytes to 8 terabytes and using interfaces, such as Universal Serial Bus (USB) 2.0, USB 3.0, external SATA, FireWire and Ethernet network connections. Certain branded products models include software that assists customers with back up, remote access and management of digital content. Branded products also include its home entertainment and networking products. Its branded products include My Book and WD Elements Desktop family of storage appliances. My Passport and WD Elements Portable family of storage appliances include WD ShareSpace, WD TV and WD Livewire.
My Book and WD Elements Desktop family of storage appliances are designed to add external capacity to desktops and digital video recorders (DVRs), allow for the transfer and storage of videos directly from certain camcorders, and connect to networks to simplify storage for consumers. My Passport and WD Elements Portable family of storage appliances are designed for external portability weighing less than one-half of a pound and allow for the transfer and storage of videos directly from certain camcorders. WD ShareSpace is a network-attached storage system designed for home office or small office applications. WD TV m! edia play! ers connect to a user�� television or home theater system and play digital movies, music and photos from an integrated hard drive, network hard drives, any of its WD-branded external hard drives, other USB mass storage devices or content services accessed over the Internet. WD Livewire, which enables consumers to use their existing electrical outlets to extend Internet connections throughout the home.
Consumer Electronics Products
WD AV family of hard drives is designed for use in products, such as DVRs and audio and video applications. WD AV drives deliver the characteristics CE manufacturers.
Enterprise Storage Products
Enterprise consists of hard drives for traditional enterprise and nearline storage applications, as well as solid-state drives for embedded applications. Its hard drive enterprise unit shipments were 10 million, for fiscal 2011. Its enterprise storage products include WD S25 hard drive, WD VelociRaptor, WD RE and WD SiliconDrive. WD S25 hard drive is designed for mission-critical enterprise server and storage applications, such as data centers and data arrays. WD VelociRaptor hard drive is designed for enterprise server and storage applications. This hard drive is also used in the high-end desktop PC market for applications including gaming, servers and advanced computer-aided design/computer-aided manufacturing (CAD/CAM) systems. WD RE family of hard drives is designed for nearline storage enterprise applications. WD SiliconDrive family of solid-state drives features fast read/write speeds in high capacities and is designed for embedded system OEM applications.
The Company competes with Hitachi Global Storage Technologies, Intel Corporation, Micron Technology, Inc., Samsung Electronics Co. Ltd., Seagate Technology, STEC, Inc. and Toshiba Corporation.
Advisors' Opinion:- [By ICRAOnline]
The Xyratex buy could put Seagate ahead of archrival Western Digital (WDC), which reported better-than-expected second-quarter earnings last week and posted a 3.9% revenue growth.
- [By John Divine]
Digital storage company Western Digital (NASDAQ: WDC ) rounds out today's list of laggards, tumbling 5.9% after its net income fell 44% in the fiscal fourth quarter. Western Digital's fall from grace exemplifies the declining PC market, as Western Digital's hard drives become less and less relevant in an era of shifting consumer tastes. Most mobile devices use chips to store data instead of the antiquated hard drive, a fact evidenced by a 22% revenue slump in the recent quarter.
- [By Tim Brugger]
HGST, a wholly owned subsidiary of Western Digital (NASDAQ: WDC ) , has entered into an agreement whereby HGST will acquire a 100% ownership stake in sTec (NASDAQ: STEC ) in an all-cash transaction valued at $340 million, equal to $6.85 a share, the companies announced today.
No comments:
Post a Comment